Economy/Home · Economy

Pepton Shares Plunge Nearly 8%, Falling Below 150,000 Won as KOSDAQ Turns Weak

Pepton (087010) is showing a steep decline of nearly 8% in the latter half of the trading session on the 8th. As of 2:48 p.m. that day, Pepton was trading at 147,500 won, down 12,700 won (7.93%) from the previous trading day. ▲ The Two Main Indices Move in Opposite Directions... Pepton's Decline D

Oseong Kwon
Staff Reporter
4 min read
Pepton Shares Plunge Nearly 8%, Falling Below 150,000 Won as KOSDAQ Turns Weak
CBC News

Pepton (087010) is showing a steep decline of nearly 8% in the latter half of the trading session on the 8th.

As of 2:48 p.m. that day, Pepton was trading at 147,500 won, down 12,700 won (7.93%) from the previous trading day.

▲ The Two Main Indices Move in Opposite Directions... Pepton's Decline Deepens

The KOSDAQ index showed strength during the session but gave up its gains and turned weak. At the same time, the KOSDAQ was at 821.96, down 0.23 points (0.02%) from the previous session. Meanwhile, the KOSPI maintained its upward trend, rising 56.27 points (0.80%) to 7,051.66.

With the two main indices moving in opposite directions, Pepton is showing a larger decline than the KOSDAQ index. In particular, as the share price has been pushed below the 150,000-won level, attention is focused on whether the stock can narrow its losses toward the end of the session and whether it will rebound going forward. However, intraday share prices can change quickly depending on supply and demand and market conditions, so the trend needs to be monitored.

▲ 89 Billion Won Investment in Second Osong Plant... Completion Date Extended to February 2028

Meanwhile, Pepton filed a correction disclosure on the 3rd, announcing a change in the period of its new facility investment following the selection of a construction company and the concretization of the construction schedule. Accordingly, the scheduled investment completion date was extended from the previous June 30, 2027, to February 15, 2028.

The investment is aimed at building a dedicated production facility for long-acting pharmaceuticals meeting current Good Manufacturing Practice (cGMP) standards for drugs, in order to expand overseas. The company will build a second plant in Osong-eup, Cheongju, North Chungcheong Province, with an investment of 89 billion won.

[※ This article is for investment reference purposes only, and investment decisions and responsibilities lie with the investor.]

Oseong Kwon
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.